These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
317 related items for PubMed ID: 8667252
1. Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process. Smith RJ, Sly LM. J Pharmacol Exp Ther; 1996 Jun; 277(3):1801-13. PubMed ID: 8667252 [Abstract] [Full Text] [Related]
2. Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma. Cuzzocrea S, Mazzon E, Dugo L, Patel NS, Serraino I, Di Paola R, Genovese T, Britti D, De Maio M, Caputi AP, Thiemermann C. Arthritis Rheum; 2003 Dec; 48(12):3544-56. PubMed ID: 14674008 [Abstract] [Full Text] [Related]
3. Oleuropein aglycone, an olive oil compound, ameliorates development of arthritis caused by injection of collagen type II in mice. Impellizzeri D, Esposito E, Mazzon E, Paterniti I, Di Paola R, Morittu VM, Procopio A, Britti D, Cuzzocrea S. J Pharmacol Exp Ther; 2011 Dec; 339(3):859-69. PubMed ID: 21880869 [Abstract] [Full Text] [Related]
4. Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic. Salvemini D, Mazzon E, Dugo L, Serraino I, De Sarro A, Caputi AP, Cuzzocrea S. Arthritis Rheum; 2001 Dec; 44(12):2909-21. PubMed ID: 11762952 [Abstract] [Full Text] [Related]
5. Effects of combination M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis. Cuzzocrea S, Mazzon E, Paola RD, Genovese T, Muià C, Caputi AP, Salvemini D. Arthritis Rheum; 2005 Jun; 52(6):1929-40. PubMed ID: 15934059 [Abstract] [Full Text] [Related]
6. CGS 21680, an agonist of the adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis. Mazzon E, Esposito E, Impellizzeri D, DI Paola R, Melani A, Bramanti P, Pedata F, Cuzzocrea S. J Rheumatol; 2011 Oct; 38(10):2119-29. PubMed ID: 21765105 [Abstract] [Full Text] [Related]
7. Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Britti D, De Maio M, Caputi AP. Eur Cytokine Netw; 2001 Oct; 12(4):568-80. PubMed ID: 11781183 [Abstract] [Full Text] [Related]
8. Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse. Cuzzocrea S, Mazzon E, di Paola R, Genovese T, Patel NS, Britti D, de Majo M, Caputi AP, Thiemermann C. Arthritis Rheum; 2005 Mar; 52(3):940-50. PubMed ID: 15751086 [Abstract] [Full Text] [Related]
9. Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats. Cuzzocrea S, Mazzon E, Bevilaqua C, Costantino G, Britti D, Mazzullo G, De Sarro A, Caputi AP. Br J Pharmacol; 2000 Dec; 131(7):1399-407. PubMed ID: 11090113 [Abstract] [Full Text] [Related]
10. Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritis. Cuzzocrea S, McDonald MC, Mota-Filipe H, Mazzon E, Costantino G, Britti D, Mazzullo G, Caputi AP, Thiemermann C. Arthritis Rheum; 2000 Feb; 43(2):320-8. PubMed ID: 10693871 [Abstract] [Full Text] [Related]
11. Anti-arthritic properties of FK506 on collagen-induced arthritis in rats. Magari K, Nishigaki F, Sasakawa T, Ogawa T, Miyata S, Ohkubo Y, Mutoh S, Goto T. Inflamm Res; 2003 Dec; 52(12):524-9. PubMed ID: 14991082 [Abstract] [Full Text] [Related]
12. Effects of various anti-inflammatory drugs on type II collagen-induced arthritis in rats. Phadke K, Carroll J, Nanda S. Clin Exp Immunol; 1982 Mar; 47(3):579-86. PubMed ID: 6979443 [Abstract] [Full Text] [Related]
13. Effects of antiarthritic compounds on type II collagen-induced arthritis in rats. Probert AW, Schrier DJ, Gilbertsen RB. Arch Int Pharmacodyn Ther; 1984 May; 269(1):167-76. PubMed ID: 6466005 [Abstract] [Full Text] [Related]
14. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data. Bendele A, McAbee T, Sennello G, Frazier J, Chlipala E, McCabe D. Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773 [Abstract] [Full Text] [Related]
15. Amelioration of type II collagen induced arthritis in rats by treatment with thymulin. Aono H, Morishita M, Sasano M, Okamoto M, Okahara A, Nakata K, Mita S. J Rheumatol; 1997 Aug; 24(8):1564-9. PubMed ID: 9263152 [Abstract] [Full Text] [Related]
16. Synergistic interaction between methotrexate and a superoxide dismutase mimetic: pharmacologic and potential clinical significance. Cuzzocrea S, Mazzon E, di Paola R, Genovese T, Muià C, Caputi AP, Salvemini D. Arthritis Rheum; 2005 Dec; 52(12):3755-60. PubMed ID: 16320326 [Abstract] [Full Text] [Related]
17. Effects of Sandimmune neoral on collagen-induced arthritis in DA rats: characterization by high resolution three-dimensional magnetic resonance imaging and by histology. Beckmann N, Bruttel K, Schuurman H, Mir A. J Magn Reson; 1998 Mar; 131(1):8-16. PubMed ID: 9533900 [Abstract] [Full Text] [Related]
18. Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats. Yamamoto N, Sakai F, Yamazaki H, Kawai Y, Nakahara K, Okuhara M. J Rheumatol; 1996 Oct; 23(10):1778-83. PubMed ID: 8895158 [Abstract] [Full Text] [Related]
19. NE-58095: a diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis. Francis MD, Hovancik K, Boyce RW. Int J Tissue React; 1989 Oct; 11(5):239-52. PubMed ID: 2517540 [Abstract] [Full Text] [Related]
20. Therapeutic effects of glucosides of Cheanomeles speciosa on collagen-induced arthritis in mice. Zhang LL, Wei W, Yan SX, Hu XY, Sun WY. Acta Pharmacol Sin; 2004 Nov; 25(11):1495-501. PubMed ID: 15525473 [Abstract] [Full Text] [Related] Page: [Next] [New Search]